Fibromyalgia

A chronic widespread pain condition. Research-stage HBOT indication; Efrati et al. 2015 showed significant symptom improvement and brain-imaging changes after 40 sessions at 2.0 ATA. Not FDA-approved; typically off-label.

Explore Related HBOT Topics

• Hyperbaric chamber types — monoplace, multiplace, hard-shell, soft-shell, and portable chamber specifications.
• HBOT conditions and indications — evidence-based reference across 20+ indications.
• Treatment protocols — pressure levels (1.3–2.8 ATA) and course schedules by indication.
• Research library — peer-reviewed evidence base organised by evidence tier.
• Safety guidelines — contraindications, screening, and in-chamber safety practice.
• Regulatory status — UHMS indications, FDA clearances, and CMS reimbursement.